Literature DB >> 7376822

Epilepsy and other factors in the prognosis of gliomas.

G M Scott, F B Gibberd.   

Abstract

A study of 95 patients with gliomas has been made. The 50% survival was 15 months after the first symptom. At the time of presentation all patients had an abnormal brain scan and E.E.G. except some of those who presented with epilepsy. The patients with epilepsy had a significantly better prognosis than those without and this was not due to their having less malignant tumours according to histological appearance. Other factors which were associated with significantly longer survival were a younger age at presentation, partial removal of the tumour rather than biopsy or no operation, lower histological grades of tumour and treatment with radiotherapy or chemotherapy.

Entities:  

Mesh:

Year:  1980        PMID: 7376822     DOI: 10.1111/j.1600-0404.1980.tb01487.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  13 in total

1.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

Authors:  M A Hammoud; R Sawaya; W Shi; P F Thall; N E Leeds
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery.

Authors:  M L van Veelen; C J Avezaat; J M Kros; W van Putten; C Vecht
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

3.  Morbidity in patients with intracranial gliomas.

Authors:  F B Gibberd; G M Scott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-05       Impact factor: 10.154

4.  Human glioma cells induce hyperexcitability in cortical networks.

Authors:  Susan L Campbell; Susan C Buckingham; Harald Sontheimer
Journal:  Epilepsia       Date:  2012-06-18       Impact factor: 5.864

5.  Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.

Authors:  Pattana Wangaryattawanich; Masumeh Hatami; Jixin Wang; Ginu Thomas; Adam Flanders; Justin Kirby; Max Wintermark; Erich S Huang; Ali Shojaee Bakhtiari; Markus M Luedi; Syed S Hashmi; Daniel L Rubin; James Y Chen; Scott N Hwang; John Freymann; Chad A Holder; Pascal O Zinn; Rivka R Colen
Journal:  Neuro Oncol       Date:  2015-07-22       Impact factor: 12.300

6.  Early prognosis of supratentorial grade 2 astrocytomas in adult patients after resection or stereotactic biopsy. An analysis of 50 cases operated on between 1984 and 1988.

Authors:  H J Steiger; R V Markwalder; R W Seiler; U Ebeling; H J Reulen
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

7.  Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas.

Authors:  J H Kim; P O Guimaraes; M Y Shen; L M Masukawa; D D Spencer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

8.  Epilepsy in the end-of-life phase in patients with high-grade gliomas.

Authors:  Andrea Pace; Veronica Villani; Cherubino Di Lorenzo; Lara Guariglia; Marta Maschio; Alfredo Pompili; Carmine Maria Carapella
Journal:  J Neurooncol       Date:  2012-10-20       Impact factor: 4.130

9.  The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management.

Authors:  D F Smith; J L Hutton; D Sandemann; P M Foy; M D Shaw; I R Williams; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

10.  Prediagnostic symptoms and signs of adult glioma: the patients' view.

Authors:  Marthe C M Peeters; Linda Dirven; Johan A F Koekkoek; Ellen G Gortmaker; Lara Fritz; Maaike J Vos; Martin J B Taphoorn
Journal:  J Neurooncol       Date:  2020-01-01       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.